SENTI BIOSCIENCES INC (SNTI)
US81726A1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to SNTI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is -7.77% below the current price.
SNTI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SNTI.
In the previous month the buy percentage consensus was at a similar level.
SNTI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-02 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-08-15 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-03-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-03-23 | Chardan Capital | Maintains | Buy |
| 2023-01-30 | Chardan Capital | Maintains | Buy |
| 2023-01-27 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-16 | JP Morgan | Initiate | Neutral |
| 2022-10-07 | Morgan Stanley | Initiate | Equal-Weight |
| 2022-09-29 | B of A Securities | Initiate | Buy |
| 2022-09-23 | Chardan Capital | Initiate | Buy |